These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14751674)

  • 1. Preliminary characterisation of an in vitro paradigm for the study of the delayed effects of organophosphorus compounds: hen embryo brain spheroids.
    Sales KM; Kingston ST; Doyle KM; Purcell WM
    Toxicology; 2004 Feb; 195(2-3):187-202. PubMed ID: 14751674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
    Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
    J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.
    Makhaeva GF; Rudakova EV; Hein ND; Serebryakova OG; Kovaleva NV; Boltneva NP; Fink JK; Richardson RJ
    J Appl Toxicol; 2014 Dec; 34(12):1426-35. PubMed ID: 24395470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates.
    Malygin VV; Sokolov VB; Richardson RJ; Makhaeva GF
    J Toxicol Environ Health A; 2003 Apr; 66(7):611-25. PubMed ID: 12746136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian embryonic brain reaggregate culture system. I. Characterization for organophosphorus compound toxicity studies.
    Funk KA; Liu CH; Wilson BW; Higgins RJ
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):149-58. PubMed ID: 7904778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of O,O-dialkyl-O-chloromethylchloroformimino phosphates: interaction with neuropathy target esterase and acetylcholinesterase.
    Makhaeva GF; Filonenko IV; Yankovskaya VL; Fomicheva SB; Malygin VV
    Neurotoxicology; 1998; 19(4-5):623-8. PubMed ID: 9745921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potencies of the four stereoisomers of isomalathion for inhibition of hen brain acetylcholinesterase and neurotoxic esterase in vitro.
    Jianmongkol S; Berkman CE; Thompson CM; Richardson RJ
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):342-8. PubMed ID: 8806851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biosensor detection of neuropathy target esterase in whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
    Makhaeva GF; Sigolaeva LV; Zhuravleva LV; Eremenko AV; Kurochkin IN; Malygin VV; Richardson RJ
    J Toxicol Environ Health A; 2003 Apr; 66(7):599-610. PubMed ID: 12746135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk.
    Richardson RJ; Moore TB; Kayyali US; Fowke JH; Randall JC
    Fundam Appl Toxicol; 1993 Apr; 20(3):273-9. PubMed ID: 7684990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
    Funk KA; Liu CH; Higgins RJ; Wilson BW
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions in vitro of some organophosphoramidates with neuropathy target esterase and acetylcholinesterase of hen brain.
    Jokanovic M; Johnson MK
    J Biochem Toxicol; 1993 Mar; 8(1):19-31. PubMed ID: 8492300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative in vitro method for detecting neuropathic compounds based on acetylcholinesterase inhibition and on inhibition and aging of neuropathy target esterase (NTE).
    Sogorb MA; González-González I; Pamies D; Vilanova E
    Toxicol In Vitro; 2010 Apr; 24(3):942-52. PubMed ID: 20097283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
    Wu SY; Casida JE
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):195-202. PubMed ID: 8685903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study of the neuropathic potential of the organophosphorus compounds fenamiphos and profenofos: Comparison with mipafox and paraoxon.
    Emerick GL; Fernandes LS; de Paula ES; Barbosa F; dos Santos NA; dos Santos AC
    Toxicol In Vitro; 2015 Aug; 29(5):1079-87. PubMed ID: 25910916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy.
    Emerick GL; DeOliveira GH; dos Santos AC; Ehrich M
    Chem Biol Interact; 2012 Sep; 199(3):177-84. PubMed ID: 22819951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated small doses of a neurotoxic organophosphate. Monitoring of neurotoxic esterase in brain and spinal cord.
    Lotti M; Johnson MK
    Arch Toxicol; 1980 Oct; 45(4):263-71. PubMed ID: 7447700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical, histopathological and clinical evaluation of delayed effects caused by methamidophos isoforms and TOCP in hens: ameliorative effects using control of calcium homeostasis.
    Emerick GL; Ehrich M; Jortner BS; Oliveira RV; Deoliveira GH
    Toxicology; 2012 Dec; 302(1):88-95. PubMed ID: 22974967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo assessment of the effect of impurities and chirality on methamidophos-induced neuropathy target esterase aging.
    Kellner T; Sanborn J; Wilson B
    Toxicol Sci; 2000 Apr; 54(2):408-15. PubMed ID: 10774823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
    Kropp TJ; Richardson RJ
    J Toxicol Environ Health A; 2003 Jun; 66(12):1145-57. PubMed ID: 12791540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro study of the inhibition of human and hen esterases by methamidophos enantiomers.
    Emerick GL; DeOliveira GH; Oliveira RV; Ehrich M
    Toxicology; 2012 Feb; 292(2-3):145-50. PubMed ID: 22198100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.